193 related articles for article (PubMed ID: 27399926)
1. Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
Melo MA; Carvalho JS; Feitosa FE; Araujo Júnior E; Peixoto AB; Costa Carvalho FH; Carvalho RC
Rev Bras Ginecol Obstet; 2016 Jun; 38(6):308-13. PubMed ID: 27399926
[TBL] [Abstract][Full Text] [Related]
2. Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.
de Jong JS; Rietveld K; van Lochem LT; Bouma BJ
Eur J Heart Fail; 2009 Feb; 11(2):220-2. PubMed ID: 19168522
[TBL] [Abstract][Full Text] [Related]
3. Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline.
Shibuya Y; Shiba M; Hayashi T; Iwai S; Mitake A; Mori N; Ichibori Y; Minamiguchi H; Makino N; Hirayama A; Higuchi Y
Intern Med; 2023 Jul; 62(14):2085-2088. PubMed ID: 36418104
[TBL] [Abstract][Full Text] [Related]
4. [Peripartum Cardiomyopathy].
Pfeffer TJ; König T; Berliner D; Bauersachs J
Dtsch Med Wochenschr; 2022 Nov; 147(23):1537-1544. PubMed ID: 36384155
[TBL] [Abstract][Full Text] [Related]
5. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
[TBL] [Abstract][Full Text] [Related]
6. [Patient with sudden cardiac arrest, peripartum cardiomyopathy and pulmonary embolism].
Lewandowski A; Syska-Sumińska J; Załęska-Zydlewska I; Grzywanowska-Łaniewska I; Wsól A; Dłużniewski M
Kardiol Pol; 2013; 71(7):741-3. PubMed ID: 23907909
[TBL] [Abstract][Full Text] [Related]
7. Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives.
Kryczka KE; Demkow M; Dzielinska Z
Ginekol Pol; 2021; 92(2):147-152. PubMed ID: 33084016
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Hilfiker-Kleiner D; Haghikia A; Berliner D; Vogel-Claussen J; Schwab J; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kindermann I; Kühl U; Angermann CE; Schlitt A; Fischer D; Podewski E; Böhm M; Sliwa K; Bauersachs J
Eur Heart J; 2017 Sep; 38(35):2671-2679. PubMed ID: 28934837
[TBL] [Abstract][Full Text] [Related]
9. [Peripartum cardiomyopathy].
Bretler DM; Jørgensen CH; Olesen JB; Gislason GH; Hansen PR
Ugeskr Laeger; 2009 Jan; 171(1-2):53-5. PubMed ID: 19128569
[TBL] [Abstract][Full Text] [Related]
10. Peripartum cardiomyopathy.
Palmer DG
J Perinat Neonatal Nurs; 2006; 20(4):324-32. PubMed ID: 17310673
[TBL] [Abstract][Full Text] [Related]
11. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
Rains CP; Bryson HM; Fitton A
Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
[TBL] [Abstract][Full Text] [Related]
12. [Gender effect on cardiomyopathy].
Biagini E; Berardini A; Graziosi M; Rosmini S; Pazzi C; Rapezzi C
G Ital Cardiol (Rome); 2012 Jun; 13(6):424-31. PubMed ID: 22622122
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Peripartum Cardiomyopathy: A Call to Action.
Cardona-Guarache R; Kron J
Can J Cardiol; 2015 Dec; 31(12):1418-20. PubMed ID: 26164124
[No Abstract] [Full Text] [Related]
14. Recovery from peripartum cardiomyopathy in a Japanese woman after administration of bromocriptine as a new treatment option.
Abe T; Amano I; Sawa R; Akira S; Nakai A; Takeshita T
J Nippon Med Sch; 2010 Aug; 77(4):226-30. PubMed ID: 20818143
[TBL] [Abstract][Full Text] [Related]
15. The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
Desplantie O; Tremblay-Gravel M; Avram R; Marquis-Gravel G; Ducharme A; Jolicoeur EM;
Can J Cardiol; 2015 Dec; 31(12):1421-6. PubMed ID: 26160409
[TBL] [Abstract][Full Text] [Related]
16. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
Hilfiker-Kleiner D; Struman I; Hoch M; Podewski E; Sliwa K
Curr Heart Fail Rep; 2012 Sep; 9(3):174-82. PubMed ID: 22729360
[TBL] [Abstract][Full Text] [Related]
17. An airport meeting that led to bromocriptine use in peripartum cardiomyopathy.
Nicholls M
Eur Heart J; 2016 Nov; 37(44):3313-3314. PubMed ID: 28007932
[No Abstract] [Full Text] [Related]
18. ED echocardiography for peripartum cardiomyopathy.
Chan L; Hill D
Am J Emerg Med; 1999 Oct; 17(6):578-80. PubMed ID: 10530538
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
[TBL] [Abstract][Full Text] [Related]
20. Cabergoline in the Treatment of Peripartum Cardiomyopathy.
Fett JD
Rev Bras Ginecol Obstet; 2016 Aug; 38(8):423-4. PubMed ID: 27583690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
